Article
The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.
Cerebrovascular diseases (Basel, Switzerland) - 1 Jan 2007
Cervera A, Tàssies D, Obach V, Amaro S, Reverter J C, Chamorro A
Abstract excerpt
BACKGROUND: The contribution of genetic factors to aspirin treatment failure (ATF) for secondary prevention is not settled in patients with ischemic stroke. METHODS: We assessed the polymorphisms VNTR (A, B, C, D) of glycoprotein (GP) Ibalpha, 807C/T of GP Ia/IIa, and Pl(A1/A2) of GP IIb/IIIa, an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
